Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells
- Rebekka Duhen
- , Carmen Ballesteros-Merino
- , Alexandra K. Frye
- , Eric Tran
- , Venkatesh Rajamanickam
- , Shu Ching Chang
- , Yoshinobu Koguchi
- , Carlo B. Bifulco
- , Brady Bernard
- , Rom S. Leidner
- , Brendan D. Curti
- , Bernard A. Fox
- , Walter J. Urba
- , R. Bryan Bell
- , Andrew D. Weinberg
Research output: Contribution to journal › Article › peer-review
131
Scopus
citations